Cargando…
Magnetic resonance venography to assess thrombus resolution with edoxaban monotherapy versus parenteral anticoagulation/warfarin for symptomatic deep vein thrombosis: A multicenter feasibility study
The feasibility of magnetic resonance venography (MRV) for measuring change in thrombus volume with a novel anticoagulation regimen versus standard anticoagulation in patients with symptomatic deep vein thrombosis (DVT) has not been assessed. Our aim was to study the feasibility of MRV to measure ch...
Autores principales: | Piazza, Gregory, Mani, Venkatesh, Goldhaber, Samuel Z, Grosso, Michael A, Mercuri, Michele, Lanz, Hans J, Schussler, Steven, Hsu, Ching, Chinigo, Amy, Ritchie, Bruce, Nadar, Venkatesh, Cannon, Kevin, Pullman, John, Concha, Mauricio, Schul, Marlin, Fayad, Zahi A |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
SAGE Publications
2016
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4963800/ https://www.ncbi.nlm.nih.gov/pubmed/27165711 http://dx.doi.org/10.1177/1358863X16645853 |
Ejemplares similares
-
Genetics and clinical response to warfarin and edoxaban in patients with venous thromboembolism
por: Vandell, Alexander G, et al.
Publicado: (2017) -
Quality of life in patients with pulmonary embolism treated with edoxaban versus warfarin
por: Bavalia, Roisin, et al.
Publicado: (2021) -
Single-dose ciraparantag safely and completely reverses anticoagulant effects of edoxaban
por: Ansell, Jack E., et al.
Publicado: (2017) -
Edoxaban versus warfarin in vitamin K antagonist experienced and naïve patients from the edoxaban versus warfarin in subjects undergoing cardioversion of atrial fibrillation (ENSURE-AF) randomised trial
por: Kozieł, Monika, et al.
Publicado: (2020) -
Concomitant Use of Single Antiplatelet Therapy With Edoxaban or Warfarin in Patients With Atrial Fibrillation: Analysis From the ENGAGE AF‐TIMI48 Trial
por: Xu, Haiyan, et al.
Publicado: (2016)